Principais efeitos colaterais das drogas antiobsessivas e seu manejo

Principais efeitos colaterais das drogas antiobsessivas e seu manejo

<abstract language="eng">Selective serotonin reuptake inhibitors (SSRIs), clomipramine, and behavior therapy are the first line treatments for obsessive-compulsive (OCD) symptoms. One of the main reasons for treatment non-compliance and early discontinuation of medications by patient...

Full description

Bibliographic Details
Main Author:	Aristides V Cordioli
Format:	Article
Language:	English
Published:	Associação Brasileira de Psiquiatria (ABP) 2001-10-01
Series:	Brazilian Journal of Psychiatry
Subjects:	Obsessive-compulsive disorder Treatment Selective serotonin reuptake inhibitors Clomipramine Adverse effects Management
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462001000600017

Similar Items

Tratamento farmacológico do transtorno obsessivo-compulsivo
by: Carla Marques
Published: (2001-10-01)

Citalopram Improves Obsessive-Compulsive Crossword Puzzling in Frontotemporal Dementia
by: Sebastian Meyer, et al.
Published: (2019-03-01)

Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: A retrospective case review from South Asia
by: Arshad Hussain, et al.
Published: (2015-01-01)

The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
by: Vijaya Padma Kotapati, et al.
Published: (2019-08-01)

‎ Lamotrigine Augmentation versus Placebo in Serotonin ‎Reuptake Inhibitors-‎Resistant Obsessive-Compulsive Disorder: ‎A Randomized Controlled Trial
by: Mohammadrasoul Khalkhali, et al.
Published: (2016-06-01)

Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial
by: Mats B. Humble, MD, et al.
Published: (2016-09-01)

Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
by: Giuseppe Maina, et al.
Published: (2009-03-01)

Neurological examination in obsessive-compulsive disorder
by: Paulo Caramelli, et al.

Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
by: Francesco Perris, et al.
Published: (2019-06-01)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
by: Jiao Xu, et al.
Published: (2021-09-01)

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2021-08-01)

Management of obsessive compulsive disorder induced by the use of clozapine
by: Yunus Emre Donmez, et al.
Published: (2019-06-01)

Comparing the Effects of Clomipramine and Fluoxetine on Fasting Blood Glucose in Children With Obsessive-Compulsive Disorder
by: Reza Torkzaban, et al.
Published: (2006-03-01)

Comparing the Effects of Clomipramine and Fluoxetine on Fasting Blood Glucose in Children With Obsessive-Compulsive Disorder
by: Reza Torkzaban, et al.
Published: (2006-04-01)

Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
by: Marzieh Azizi, et al.
Published: (2019-09-01)

Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients
by: Kostev, Karel, et al.
Published: (2014-10-01)

Chirality of Modern Antidepressants: An Overview
by: Monica Budău, et al.
Published: (2017-12-01)

Refining the clinical features of serotonin syndrome: A prospective observational study of 45 patients
by: Sanjay Prakash, et al.
Published: (2019-01-01)

Suicidality and Suicide Attempt in a Young Female on Long-Term Sertraline Treatment
by: Ranjita Santra, et al.
Published: (2012-01-01)

Review of sexual dysfunction due to selective serotonin reuptake inhibitors
by: P Srilakshmi, et al.
Published: (2012-01-01)

Paroxetine Induced Akathisia: Necessity for Rational Use
by: Maryam Mousavi, et al.
Published: (2019-07-01)

Pagophagia – A Common but Rarely Reported Form of Pica
by: M.S. BHATIA, et al.
Published: (2014-01-01)

Selective serotonin reuptake inhibitors-paroxetine induced galactorrhea in a case of somatoform disorder
by: Ajay Halder, et al.
Published: (2015-01-01)

Stimulant and SSRI Medication Trends in ADHD
by: J Gordon Millichap
Published: (2001-06-01)

Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
by: Mohammad Hassan Nezafati, et al.
Published: (2016-01-01)

Selective serotonin reuptake inhibitors and risk for gastrointestinal bleeding
by: Batić-Mujanović Olivera, et al.
Published: (2014-01-01)

Thrombocytopenia due to escitalopram use – A rare case report at the emergency department
by: Cihan Bedel, et al.
Published: (2021-01-01)

A study to understand the pattern of hyponatremia in patients using selective serotonin reuptake inhibitors and serotonin dopamine antagonists
by: Love Kumar Tomar, et al.
Published: (2021-01-01)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
by: Maximilian Gahr, et al.
Published: (2020-02-01)

Antidepressant Drugs Effects on Blood Pressure
by: Anna Calvi, et al.
Published: (2021-08-01)

Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm
by: Michael P. Hengartner
Published: (2017-12-01)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
by: Zhong Z, et al.
Published: (2017-11-01)

Molecular mechanism of noradrenaline during the stress-induced major depressive disorder
by: Kenjiro Seki, et al.
Published: (2018-01-01)

Intense suicidal thoughts and self-harm following escitalopram treatment
by: Farooq Khan, et al.
Published: (2011-01-01)

Depressive disorders in cardiology practice : Diagnosis and treatment
by: F. Yu. Kopylov
Published: (2014-07-01)

Clinical description of affective disorders and efficiency of antidepressant therapy
by: E. V. Lebedeva, et al.
Published: (2018-12-01)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011-01-01)

Depressive disorders in cardiology practice : Diagnosis and treatment
by: F. Yu. Kopylov
Published: (2014-07-01)

Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study
by: Robyn P. Thom, et al.
Published: (2021-09-01)

Hypnic jerks possibly induced by escitalopram
by: Harshal Sathe, et al.
Published: (2015-03-01)

Cannot write session to /tmp/vufind_sessions/sess_h5o2e34768h6kpqgfc9gp1ine6